Connect with us

National

Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan – Yahoo Finance

Moderna announces New Drug Application submitted to import and distribute Moderna’s COVID-19 vaccine candidate in Japan.

Published

on

Article feature image

50 million doses of Modernas COVID-19 vaccine candidate expected to be distributed beginning in the first half of 2021, pending licensure in Japan
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Takeda Pharmaceutical Co., Ltd (NYSE: TAK) submitted a New Drug Application to the Government of Japans Ministry of Health, Labour and Welfare (MHLW) to import and distribute Modernas vaccine candidate against COVID-19…

Click here to view the original article.